These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37345536)

  • 1. Exploring binding modes of the selected inhibitors to SND1 by all-atom molecular dynamics simulations.
    Pang P; Liu S; Hao X; Tian Y; Gong S; Miao D; Zhang Y
    J Biomol Struct Dyn; 2024 Jul; 42(11):5536-5550. PubMed ID: 37345536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study on the Binding Mechanism and the Impact of Key Residue Mutations between SND1 and MTDH Peptide through Molecular Dynamics Simulations.
    Liu S; Hao X; Miao D; Zhang Y
    J Phys Chem B; 2024 Sep; 128(38):9074-9085. PubMed ID: 39276108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
    Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
    Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
    Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
    Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
    Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
    Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
    Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
    Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
    Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
    Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
    Manjula S; Sivanandam M; Kumaradhas P
    J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring binding modes of the selected inhibitors to phosphodiesterase delta by all-atom molecular dynamics simulations and free energy calculations.
    Zhong H; Zhang YJ; Shan XB
    J Biomol Struct Dyn; 2019 Jun; 37(9):2415-2429. PubMed ID: 30052144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics Simulation-Driven Focused Virtual Screening and Experimental Validation of Inhibitors for MTDH-SND1 Protein-Protein Interaction.
    Xu Y; Guo X; Yan D; Dang X; Guo L; Jia T; Wang Q
    J Chem Inf Model; 2023 Jun; 63(11):3614-3627. PubMed ID: 37226724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of Metadherin-SND1 interaction in colon cancer.
    Wang N; Du X; Zang L; Song N; Yang T; Dong R; Wu T; He X; Lu J
    Mol Biol Rep; 2012 Dec; 39(12):10497-504. PubMed ID: 23065261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer.
    Makki Almansour N
    Saudi Pharm J; 2023 Oct; 31(10):101751. PubMed ID: 37693734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the drug resistance mechanism of active site, non-active site mutations and their cooperative effects in CRF01_AE HIV-1 protease: molecular dynamics simulations and free energy calculations.
    C S V; Tamizhselvi R; Munusami P
    J Biomol Struct Dyn; 2019 Jul; 37(10):2608-2626. PubMed ID: 30051758
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Issar U; Arora R; Kakkar R
    J Biomol Struct Dyn; 2024 Jun; 42(9):4537-4552. PubMed ID: 37301606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.
    Blanco MA; Alečković M; Hua Y; Li T; Wei Y; Xu Z; Cristea IM; Kang Y
    J Biol Chem; 2011 Jun; 286(22):19982-92. PubMed ID: 21478147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations.
    Song LT; Tu J; Liu RR; Zhu M; Meng YJ; Zhai HL
    J Biomol Struct Dyn; 2019 Jul; 37(11):2970-2979. PubMed ID: 30058436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlated overexpression of metadherin and SND1 in glioma cells.
    Tong L; Wang C; Hu X; Pang B; Yang Z; He Z; He M; Wei L; Chu M
    Biol Chem; 2016 Jan; 397(1):57-65. PubMed ID: 26351803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
    Rezvani S; Ebadi A; Razzaghi-Asl N
    J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.